AAAAAA

   
Results: 1-23 |
Results: 23
Comparison of two commercial assays for the detection of insertion mutations of HIV-1 reverse transcriptase
Authors: Koch, N Tamalet, C Tivoli, N Fantini, J Yahi, N
Citation: N. Koch et al., Comparison of two commercial assays for the detection of insertion mutations of HIV-1 reverse transcriptase, J CLIN VIRO, 21(2), 2001, pp. 153-162
Genetic analysis of HIV type 1 strains in Bujumbura (Burundi): Predominance of subtype C variant
Authors: Koch, N Ndihokubwayo, JB Yahi, N Tourres, C Fantini, J Tamalet, C
Citation: N. Koch et al., Genetic analysis of HIV type 1 strains in Bujumbura (Burundi): Predominance of subtype C variant, AIDS RES H, 17(3), 2001, pp. 269-273
Secondary structure predictions of HIV-1 reverse transcriptase provide newinsights into the development of drug-resistance genotypes
Authors: Fantini, J Tamalet, C Yahi, N
Citation: J. Fantini et al., Secondary structure predictions of HIV-1 reverse transcriptase provide newinsights into the development of drug-resistance genotypes, AIDS, 15(9), 2001, pp. 1191-1192
Mutations in HIV-1 gag cleavage sites and their association with protease mutations
Authors: Koch, N Yahi, N Fantini, J Tamalet, C
Citation: N. Koch et al., Mutations in HIV-1 gag cleavage sites and their association with protease mutations, AIDS, 15(4), 2001, pp. 526-528
The mycotoxin ochratoxin A alters intestinal barrier and absorption functions but has no effect on chloride secretion
Authors: Maresca, M Mahfoud, R Pfohl-Leszkowicz, A Fantini, J
Citation: M. Maresca et al., The mycotoxin ochratoxin A alters intestinal barrier and absorption functions but has no effect on chloride secretion, TOX APPL PH, 176(1), 2001, pp. 54-63
Amphiphilic anionic analogues of galactosylceramide: Synthesis, anti-HIV-1activity, and gp120 binding
Authors: Faroux-Corlay, B Greiner, J Terreux, R Cabrol-Bass, D Aubertin, AM Vierling, P Fantini, J
Citation: B. Faroux-corlay et al., Amphiphilic anionic analogues of galactosylceramide: Synthesis, anti-HIV-1activity, and gp120 binding, J MED CHEM, 44(13), 2001, pp. 2188-2203
Use of drug resistance sequence data for the systematic detection of non-Bhuman immunodeficiency virus type 1 (HIV-1) subtypes: How to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale
Authors: Yahi, N Fantini, J Tourres, C Tivoli, N Koch, N Tamalet, C
Citation: N. Yahi et al., Use of drug resistance sequence data for the systematic detection of non-Bhuman immunodeficiency virus type 1 (HIV-1) subtypes: How to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale, J INFEC DIS, 183(9), 2001, pp. 1311-1317
Gp120-induced Bob/GPR15 activation - A possible cause of human immunodeficiency virus enteropathy
Authors: Clayton, F Kotler, DP Kuwada, SK Morgan, T Stepan, C Kuang, JQ Le, J Fantini, J
Citation: F. Clayton et al., Gp120-induced Bob/GPR15 activation - A possible cause of human immunodeficiency virus enteropathy, AM J PATH, 159(5), 2001, pp. 1933-1939
Glycosphingolipids and virus-cell fusion: current data highlighting the role of membrane microdomains in the HIV-1 infection cycle
Authors: Hammache, D Yahi, N Fantini, J
Citation: D. Hammache et al., Glycosphingolipids and virus-cell fusion: current data highlighting the role of membrane microdomains in the HIV-1 infection cycle, OCL-OL CORP, 7(5), 2000, pp. 449-455
Mutation L210W of HIV-1 reverse transcriptase in patients receiving combination therapy - Incidence, association with other mutations, and effects onthe structure of mutated reverse transcriptase
Authors: Yahi, N Tamalet, C Tourres, C Tivoli, N Fantini, J
Citation: N. Yahi et al., Mutation L210W of HIV-1 reverse transcriptase in patients receiving combination therapy - Incidence, association with other mutations, and effects onthe structure of mutated reverse transcriptase, J BIOMED SC, 7(6), 2000, pp. 507-513
Total synthesis of mololipids: A new series of anti-HIV Moloka'iamine derivatives
Authors: Schoenfeld, RC Lumb, JP Fantini, J Ganem, B
Citation: Rc. Schoenfeld et al., Total synthesis of mololipids: A new series of anti-HIV Moloka'iamine derivatives, BIOORG MED, 10(23), 2000, pp. 2679-2681
Synthesis of glycolipid analogues that disrupt binding of HIV-1 gp120 to galactosylceramide
Authors: Weber, KT Hammache, D Fantini, J Ganem, B
Citation: Kt. Weber et al., Synthesis of glycolipid analogues that disrupt binding of HIV-1 gp120 to galactosylceramide, BIOORG MED, 10(10), 2000, pp. 1011-1014
Glycosphingolipid (GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: Activation of signaltransduction pathways and perturbations of intestinal absorption and secretion
Authors: Fantini, J Maresca, M Hammache, D Yahi, N Delezay, O
Citation: J. Fantini et al., Glycosphingolipid (GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: Activation of signaltransduction pathways and perturbations of intestinal absorption and secretion, GLYCOCON J, 17(3-4), 2000, pp. 173-179
Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion
Authors: Fantini, J Hammache, D Pieroni, G Yahi, N
Citation: J. Fantini et al., Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion, GLYCOCON J, 17(3-4), 2000, pp. 199-204
Reconstitution of sphingolipid-cholesterol plasma membrane microdomains for studies of virus-glycolipid interactions
Authors: Hammache, D Pieroni, G Maresca, M Ivaldi, S Yahi, N Fantini, J
Citation: D. Hammache et al., Reconstitution of sphingolipid-cholesterol plasma membrane microdomains for studies of virus-glycolipid interactions, METH ENZYM, 312, 2000, pp. 495-506
Synthetic soluble analogs of glycolipids for studies of virus-glycolipid interactions
Authors: Fantini, J
Citation: J. Fantini, Synthetic soluble analogs of glycolipids for studies of virus-glycolipid interactions, METH ENZYM, 311, 2000, pp. 626-638
Multidrug resistance genotypes (insertions in the beta 3-beta 4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: Incidence and association with other resistance mutations
Authors: Tamalet, C Yahi, N Tourres, C Colson, P Quinson, AM Poizot-Martin, I Dhiver, C Fantini, J
Citation: C. Tamalet et al., Multidrug resistance genotypes (insertions in the beta 3-beta 4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: Incidence and association with other resistance mutations, VIROLOGY, 270(2), 2000, pp. 310-316
Synthesis of single- and double-chain fluorocarbon and hydrocarbon galactosyl amphiphiles and their anti-HIV-1 activity
Authors: Faroux-Corlay, B Clary, L Gadras, C Hammache, D Greiner, J Santaella, C Aubertin, AM Vierling, P Fantini, J
Citation: B. Faroux-corlay et al., Synthesis of single- and double-chain fluorocarbon and hydrocarbon galactosyl amphiphiles and their anti-HIV-1 activity, CARBOHY RES, 327(3), 2000, pp. 223-260
Genetic polymorphism near HIV-1 reverse transcriptase resistance-associated codons is a major obstacle for the line probe assay as an alternative method to sequence analysis
Authors: Koch, N Yahi, N Colson, P Fantini, J Tamalet, C
Citation: N. Koch et al., Genetic polymorphism near HIV-1 reverse transcriptase resistance-associated codons is a major obstacle for the line probe assay as an alternative method to sequence analysis, J VIROL MET, 80(1), 1999, pp. 25-31
Comparison of human immunodeficiency virus type 1 (HIV-1) protease mutations in HIV-1 genomes detected in plasma and in peripheral blood mononuclear cells from patients receiving combination drug therapy
Authors: Koch, N Yahi, N Ariasi, F Fantini, J Tamalet, C
Citation: N. Koch et al., Comparison of human immunodeficiency virus type 1 (HIV-1) protease mutations in HIV-1 genomes detected in plasma and in peripheral blood mononuclear cells from patients receiving combination drug therapy, J CLIN MICR, 37(5), 1999, pp. 1595-1597
Mutation patterns of the reverse transcriptase and protease genes in humanimmunodeficiency virus type 1-infected patients undergoing combination therapy: Survey of 787 sequences
Authors: Yahi, N Tamalet, C Tourres, C Tivoli, N Ariasi, F Volot, F Gastaut, JA Gallais, H Moreau, J Fantini, J
Citation: N. Yahi et al., Mutation patterns of the reverse transcriptase and protease genes in humanimmunodeficiency virus type 1-infected patients undergoing combination therapy: Survey of 787 sequences, J CLIN MICR, 37(12), 1999, pp. 4099-4106
Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: Evidence for CD4-Induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (gb3 and GM3)
Authors: Hammache, D Yahi, N Maresca, M Pieroni, G Fantini, J
Citation: D. Hammache et al., Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: Evidence for CD4-Induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (gb3 and GM3), J VIROLOGY, 73(6), 1999, pp. 5244-5248
Glycolipids as potential binding sites for HIV: topology in the sperm plasma membrane in relation to the regulation of membrane fusion
Authors: Gadella, BM Hammache, D Pieroni, G Colenbrander, B van Golde, LMG Fantini, J
Citation: Bm. Gadella et al., Glycolipids as potential binding sites for HIV: topology in the sperm plasma membrane in relation to the regulation of membrane fusion, J REPRO IMM, 41(1-2), 1998, pp. 233-253
Risultati: 1-23 |